1-5 of 5
Yuto Nakajima
Close
Sort by
Journal Articles

Activated Protein C-Catalyzed Inactivation Pathway Down-Regulates NXT007-Mediated Hemostatic Function

Yuto Nakajima, Kenichi Ogiwara, Takehisa Kitazawa, Midori Shima, Keiji Nogami
Journal: Blood
Blood (2022) 140 (Supplement 1): 5576–5577.
https://doi.org/10.1182/blood-2022-162928
Published: 2022
Journal Articles

Escaping Ability of Human-Porcine Hybrid Factor VIII from Anti-Factor VIII Inhibitors with an A2 or C2 Epitope

Kuniyoshi Mizumachi, Yuto Nakajima, Naruto Shimonishi, Shoko Furukawa, Kenichi Ogiwara, Masahiro Takeyama, Midori Shima, Keiji Nogami
Journal: Blood
Blood (2022) 140 (Supplement 1): 8430–8431.
https://doi.org/10.1182/blood-2022-165714
Published: 2022
Journal Articles

Global Coagulation Potentials and Breakthrough Bleeds in Emicizumab-Treated Hemophilia a Patients Were Similar to Mild Hemophilia a Patients

Yuto Nakajima, Kuniyoshi Mizumachi, Naruto Shimonishi, Shoko Furukawa, Kenichi Ogiwara, Masahiro Takeyama, Midori Shima, Keiji Nogami
Journal: Blood
Blood (2021) 138 (Supplement 1): 2100.
https://doi.org/10.1182/blood-2021-146337
Published: 2021
Journal Articles

Residues 1680-1684 in the A3 Domain of Factor VIII Contain a Novel Thrombin-Interactive Site Responsible for Proteolytic Cleavage at Arg 1689

Yuto Nakajima, MD, Keiji Nogami, MD PhD, Hiroaki Minami, MD, Kana Sasai, Midori Shima, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1107.
https://doi.org/10.1182/blood-2019-129313
Published: 2019
Journal Articles

A Novel Mechanism of Factor VIIa/Tissue Factor (TF)-Catalyzed Activation and Inactivation of B-Domain-Deleted Factor VIII in the Early Initiation Phases of Coagulation

Yuto Nakajima, MD, Koji Yada, MD PhD, Keiji Nogami, MDPhD, Midori Shima, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1162.
https://doi.org/10.1182/blood-2018-99-115645
Published: 2018